CLL Foundation
Non-Profit & Charitable Organizations · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1721 North Blvd, Houston, Texas, 77098, ...Phone Number
(713) 542-1183Website
www.cllfoundation.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CLL Foundation
The CLL Foundation is dedicated to raising funds for research focused on Chronic Lymphocytic Leukemia (CLL), the most common form of adult leukemia. The organization aims to enhance understanding of the disease and improve treatment options for those diagnosed with CLL. It primarily relies on individual donations to support its mission, especially in light of financial challenges faced by research institutions. The Foundation encourages public support to continue funding vital research projects and ultimately seeks a cure for CLL.Explore more
CLL Foundation Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CLL Foundation your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if CLL Foundation had a recent Job posting/layoffs
Check out if CLL Foundation is spiking on competitors!
Check if CLL Foundation has recently received funding, and reach out quickly before it becomes old news!
CLL Foundation, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at CLL Foundation
Earning: See what the market has to say on CLL Foundation recently announced quarterly report
Product Launch: Get notified when CLL Foundation launches new products
Funding: Get notified immidiatlly once CLL Foundation has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined CLL Foundation as Masked Content
Find 3 more new buyers
Compare Similar Companies to CLL Foundation
Compare insights from companies similar to CLL Foundation, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CLL Foundation is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
CLL Foundation is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about CLL Foundation.
CLL Foundation Tech Stack
A closer look at the technologies used by CLL Foundation
CLL Foundation News & Media
AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
Addition of VENCLYXTO plus acalabrutinib, with or without obinutuzumab, and VENCLYXTO plus ibrutinib supported by data from Phase 3 AMPLIFY trial, Phase 3 GLOW trial and Phase 2 CAPTIVATE trial Fixed-duration VENCLYXTO-based combination regimens provide patients with additional CLL...AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
Addition of VENCLYXTO plus acalabrutinib, with or without obinutuzumab, and VENCLYXTO plus ibrutinib supported by data from Phase 3 AMPLIFY trial, Phase 3 GLOW trial and Phase 2 CAPTIVATE trial Fixed-duration VENCLYXTO-based combination regimens provide patients with additional CLL...U.S. Food and Drug Administration (FDA) Approves Combination Treatment of VENCLEXTA® (venetoclax) and Acalabrutinib for Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL)
First all-oral, fixed-duration combination regimen approved for previously untreated patients with CLL Approval supported by data from the Phase 3 AMPLIFY trial Regimen offers another option for the potential of time off treatment, marking a meaningful advance in long-term disease...ROR Inhibitors Market Expected to Witness Significant Growth Through 2034 Due to the Rising Oncology Research and Pipeline Advancements | DelveInsight
The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor (ROR) pathways in cancer and autoimmune diseases. Advancements in targeted therapies, especially in oncology, are fueling R&D investments in this...
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CLL Foundation
Sign Up For FreeTo access detailed company insights
The CLL Foundation is dedicated to raising funds for research focused on Chronic Lymphocytic Leukemia (CLL), the most common form of adult leukemia. The organization aims to enhance understanding of the disease and improve treatment options for those diagnosed with CLL. It primarily relies on individual donations to support its mission, especially... Read More
